Skip to content

Effects of open- and closed label nocebo and placebo verbal suggestions on itch

Effects of open- and closed label nocebo and placebo verbal suggestions on itch - Open label nocebo and placebo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43008
Enrollment
92
Registered
2016-09-21
Start date
2016-10-20
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Het onderzoek wordt bij gezonde proefpersonen uitgevoerd. Uitkomsten uit deze lijn van onderzoek bieden nieuwe handvatten voor verklaringsmodellen en therapeutische interventies voor aandoeningen waarbij jeuk een symptoom is. Not applicable

Interventions

Sponsors

Universiteit Leiden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Between 18 and 35 years old; good understanding of written and spoken Dutch

Exclusion criteria

Exclusion criteria: Refusal to give written informed consent; severe somatic or psychological morbidity (e.g., heart and lung diseases or DSM-IV psychiatric disorders) that would adversely affect participant's safety or that might interfere with the study protocol; current chronic itch or pain complaints; current use of analgesics, anti-inflammatory drugs, antihistamines, antibiotics or recent vaccinations; pregnancy

Design outcomes

Primary

MeasureTime frame
The primary study parameter is self-reported itch during histamine iontophoresis.

Secondary

MeasureTime frame
Secondary study outcomes include wheal size, flare response, skin temperature, and self-reported skin condition following histamine iontophoresis, as well as scratching behaviour. In addition, the possible influence of psychological parameters on outcomes will be explored.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)